Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
TAVR: Predicting mortality | Real-world outcomes vs. clinical trials | Next-day discharge
Tuesday, October 26, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: TAVR

Clinicians have a new tool for predicting TAVR mortality

Left atrium emptying fraction (LAEF) measurements can provide significant value during the TAVR planning process.

READ MORE >
radiology reporting EHR health record CDS AUC
Share on Twitter Share on Facebook Share on Linkedin

Clinicians have a new tool for predicting TAVR mortality

Share on Twitter Share on Facebook Share on Linkedin
radiology reporting EHR health record CDS AUC
Left atrium emptying fraction (LAEF) measurements can provide significant value during the TAVR planning process.
READ MORE >

TAVR delivers better outcomes for low-risk patients than a sutureless surgical approach

The two treatment options were comparable in many ways—but TAVR was better when it came to limiting hospitalizations for heart failure. 

READ MORE >
heart.png
Share on Twitter Share on Facebook Share on Linkedin

TAVR delivers better outcomes for low-risk patients than a sutureless surgical approach

Share on Twitter Share on Facebook Share on Linkedin
heart.png
The two treatment options were comparable in many ways—but TAVR was better when it came to limiting hospitalizations for heart failure. 
READ MORE >

Real-world TAVR outcomes highlight the accuracy of clinical trials

Clinical trial results don't always apply to real-world patient populations.

READ MORE >
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 
Share on Twitter Share on Facebook Share on Linkedin

Real-world TAVR outcomes highlight the accuracy of clinical trials

Share on Twitter Share on Facebook Share on Linkedin
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 
Clinical trial results don't always apply to real-world patient populations.
READ MORE >

Next-day discharge after TAVR is safe and effective, new meta-analysis confirms

Researchers tracked data from six different studies, focusing on the likelihood of potential issues such as bleeding and vascular complications.

READ MORE >
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Share on Twitter Share on Facebook Share on Linkedin

Next-day discharge after TAVR is safe and effective, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Researchers tracked data from six different studies, focusing on the likelihood of potential issues such as bleeding and vascular complications.
READ MORE >

98% of new TAVR programs are being developed in wealthier metro areas

The study's authors examined new TAVR programs established from 2012 to 2018.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

98% of new TAVR programs are being developed in wealthier metro areas

Share on Twitter Share on Facebook Share on Linkedin
The study's authors examined new TAVR programs established from 2012 to 2018.
READ MORE >

TAVR safe and effective for patients with cirrhosis

Patients with cirrhosis of the liver often undergo TAVR at a younger age, but the outcomes remain strong. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

TAVR safe and effective for patients with cirrhosis

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
Patients with cirrhosis of the liver often undergo TAVR at a younger age, but the outcomes remain strong. 
READ MORE >

Permanent pacemaker implantation after TAVR does not increase risk of death or heart failure

Prior studies have suggested that TAVR patients could face worse outcomes if they require a permanent pacemaker. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Permanent pacemaker implantation after TAVR does not increase risk of death or heart failure

Share on Twitter Share on Facebook Share on Linkedin
Prior studies have suggested that TAVR patients could face worse outcomes if they require a permanent pacemaker. 
READ MORE >

Just 3.6% of TAVR procedures in the US performed by women

In addition, researchers noted, there were no female specialists performing TAVR in 19 states. 

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Just 3.6% of TAVR procedures in the US performed by women

Share on Twitter Share on Facebook Share on Linkedin
women doctors
In addition, researchers noted, there were no female specialists performing TAVR in 19 states. 
READ MORE >

New TAVR system for high-risk patients gains FDA approval

The system was specifically designed for patients who should avoid open-heart surgery.  

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

New TAVR system for high-risk patients gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The system was specifically designed for patients who should avoid open-heart surgery.  
READ MORE >

TAVR and SAVR deliver similar 5-year outcomes for CKD patients

“The choice of intervention in patients with CKD and aortic stenosis is complex and influenced by multiple competing factors," researchers said. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TAVR and SAVR deliver similar 5-year outcomes for CKD patients

Share on Twitter Share on Facebook Share on Linkedin
“The choice of intervention in patients with CKD and aortic stenosis is complex and influenced by multiple competing factors," researchers said. 
READ MORE >

TAVR provides comparable value for low-risk patients with bicuspid and tricuspid AS

Researchers examined data from more than 3,000 TAVR procedures performed with balloon-expandable valves. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TAVR provides comparable value for low-risk patients with bicuspid and tricuspid AS

Share on Twitter Share on Facebook Share on Linkedin
Researchers examined data from more than 3,000 TAVR procedures performed with balloon-expandable valves. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme